Bionano Genomics (BNGO) Accumulated Depreciation & Amortization (2017 - 2024)
Historic Accumulated Depreciation & Amortization for Bionano Genomics (BNGO) over the last 8 years, with Q4 2024 value amounting to $14.0 million.
- Bionano Genomics' Accumulated Depreciation & Amortization rose 229.06% to $14.0 million in Q4 2024 from the same period last year, while for Dec 2024 it was $14.0 million, marking a year-over-year increase of 229.06%. This contributed to the annual value of $14.0 million for FY2024, which is 229.06% up from last year.
- Latest data reveals that Bionano Genomics reported Accumulated Depreciation & Amortization of $14.0 million as of Q4 2024, which was up 229.06% from -$17.4 million recorded in Q3 2024.
- Bionano Genomics' Accumulated Depreciation & Amortization's 5-year high stood at $14.0 million during Q4 2024, with a 5-year trough of -$17.4 million in Q3 2024.
- Over the past 5 years, Bionano Genomics' median Accumulated Depreciation & Amortization value was $6.5 million (recorded in 2021), while the average stood at $4.1 million.
- Its Accumulated Depreciation & Amortization has fluctuated over the past 5 years, first surged by 18710.83% in 2022, then skyrocketed by 229.06% in 2024.
- Over the past 5 years, Bionano Genomics' Accumulated Depreciation & Amortization (Quarter) stood at $1.5 million in 2020, then skyrocketed by 126.57% to $3.4 million in 2021, then skyrocketed by 187.11% to $9.6 million in 2022, then surged by 42.48% to $13.7 million in 2023, then increased by 2.29% to $14.0 million in 2024.
- Its last three reported values are $14.0 million in Q4 2024, -$17.4 million for Q3 2024, and $13.7 million during Q4 2023.